Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yasuhiro Goto
Observed names:
Y. Goto,
YASUHIRO GOTO
Institution:
Fujita Health University
Observed institution:
Fujita Health University
ORCID:
0000-0003-2235-8567
Observed ORCID:
0000-0003-2235-8567
OpenAlex ID:
A5047714774
46P Multi-center, phase II study of docetaxel (DTX) plus ramucirumab (RAM) following platinum-based chemotherapy plus ICIs in patients with NSCLC: SCORPION study
2023
·
R. Matsuzawa
, M. Morise
, et al.
·
Journal of Thoracic Oncology
·
5
PDF
Prognostic factors in patients with interstitial lung disease treated with nintedanib: a multicenter retrospective study in Japan
2025
·
Shiho Goda
, Tadaaki Yamada
, et al.
·
Scientific Reports
·
3
Severe bradycardia after amivantamab administration in a patient with epidermal growth factor receptor-positive non-small cell lung cancer: A case report.
2026
·
Shoko Kamenosono
, Aki Ikeda
, et al.
·
PubMed Central
·
1
PDF
A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non‐Small Cell Lung Cancer With Cachexia (SPIRAL‐ANA)
2026
·
Kenji Morimoto
, Junji Uchino
, et al.
·
Journal of Cachexia Sarcopenia and Muscle
·
1
Long-Term Benefit With First-Line Osimertinib Monotherapy in EGFR-Mutated Advanced NSCLC in the Era of Intensified First-Line Therapy
2026
·
Masaki Ishida
, Tadaaki Yamada
, et al.
·
Journal of Thoracic Oncology
PDF
Pneumonitis in Older Patients With Non-squamous Non-small Cell Lung Cancer Treated With Pembrolizumab and Pemetrexed
2026
·
YOSHIHITO KOGURE
, HIROYA HASHIMOTO
, et al.
·
In Vivo
PDF
Efficacy and safety of nintedanib for older adults with idiopathic pulmonary fibrosis or progressive fibrosing interstitial lung disease: A multicenter retrospective study in Japan
2026
·
Shiho Goda
, Tadaaki Yamada
, et al.
·
Respiratory Investigation
Efficacy and safety of anamorelin in patients with non–small cell lung cancer and cancer cachexia undergoing chemoimmunotherapy: A real-world prospective cohort study (SPIRAL-ANA).
2026
·
Kenji Morimoto
, Junji Uchino
, et al.
·
Journal of Clinical Oncology
Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease
2026
·
Shiho Goda
, Tadaaki Yamada
, et al.
·
BMC Pulmonary Medicine
Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR -mutant NSCLC After TKI Resistance
2026
·
HARUKA NAKATANI
, HAYATO KAWACHI
, et al.
·
Anticancer Research
Abstract 5238: Retrospective study for clinical biomarkers to guide post-EGFR-TKI treatment strategies in EGFR-mutant NSCLC
2026
·
Tadaaki Yamada
, Kenji Morimoto
, et al.
·
Cancer Research
Comparison of biomechanical assessment between upright and supine inspiratory-expiratory area-detector CT in progressive pulmonary fibrosis
2026
·
Yoshiharu Ohno
, Kota Aoyagi
, et al.
·
European Radiology Experimental
PDF
Flopropione, a Cysteine Conjugate β-Lyase 1 Inhibitor, for Prevention of Cisplatin-Induced Nephrotoxicity: Protocol for a Randomized, Open-Label, Proof-of-Concept Phase 1 and 2a Trial
2026
·
Takenao Koseki
, Masashi Kondo
, et al.
·
JMIR Research Protocols
Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study
2026
·
Yoshihito Kogure
, Hiroya Hashimoto
, et al.
·
Cancer Treatment and Research Communications
Show more works
View as search
Works count:
14
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type